Content area
Background
The prevention of vancomycin-resistant Enterococcus faecium (VREfm) infections and transmissions poses a major challenge to hospitals. Vancomycin resistance can be plasmid encoded; however, as the analysis of plasmids is challenging, so far only a few reports have provided a detailed characterization of plasmids in nosocomial VREfm transmission. Here we describe a nosocomial VREfm outbreak caused by a vanA positive ST80 isolate. vanA plasmid sequence data was used to distinguish outbreak-associated isolates from sporadic VREfm cases and to investigate the spread of this plasmid within the local VREfm population.
Methods
446 VREfm isolates were collected from routine surveillance between 01/2022 and 02/2024 and analyzed using long-read whole genome sequencing (lrWGS). Genetic relatedness of isolates was evaluated based on core genome multilocus sequence typing (cgMLST). Genetically similar vanA plasmids were identified using a Mash based approach.
Results
30 genetically similar VREfm isolates were identified in patients’ screening and environmental samples. Infection control evaluation confirmed transmission through shared hospital rooms. All outbreak-related VREfm isolates, including environmental samples, carried a highly similar vanA plasmid (Mash distance of < 0.001) with an identical replicon type. After enhanced infection control measures were established, no new transmissions were detected. Comparison with additional VREfm isolates from the respective department showed no evidence for further plasmid transmission.
Conclusions
Our study illustrates how vanA plasmid analysis can support the evaluation of VREfm transmission in hospitals. The outbreak-associated vanA plasmids were genetically highly similar, but could be clearly distinguished from other vanA plasmids in the local hospital population. Taken together, detailed analysis of hospital-associated vanA plasmids can improve our understanding of VREfm transmission and epidemiology.
Background
In July 2024, the Centers for Disease Control and Prevention (CDC) published new surveillance data concerning the antimicrobial resistance threats in the United States from 2021 to 2023 [1]. Here a significant increase in hospital onset vancomycin-resistant Enterococcus faecium (VREfm) infections was described. The most recent European antimicrobial resistance surveillance network (EARS-Net) report also describes a worrying increase in VREfm isolates in Europe [2]. VREfm poses a major concern to healthcare systems worldwide, as the bacteria can cause serious infections and frequently initiate nosocomial outbreaks [3], despite well-established surveillance efforts [4]. In recent years, whole genome sequencing (WGS) has become the gold standard to investigate potential outbreaks in the hospital setting [5]. Unfortunately, the discriminatory power of current genomic analysis methods for VREfm appears to be lower than for other multi-drug resistant organisms [6], probably due to its monomorphic population structure.
Although vancomycin resistance can be plasmid encoded, little is known about the role of these plasmids in nosocomial transmissions [6, 7], because it has previously been difficult to analyze plasmids [8, 9]. The recently developed long-read whole genome sequencing (lrWGS) technology enables the assembly of long DNA fragments including plasmids as part of routine molecular surveillance. This analysis can add an additional dimension of genetic information to outbreak investigations [10].
For this reason, we investigated a nosocomial VREfm outbreak event in our tertiary care hospital in Münster, Germany, using lrWGS technology. We characterized the outbreak-associated vancomycin resistance plasmid and compared this vanA plasmid to the local vanA plasmid landscape of our hospital. Our results demonstrate that lrWGS can be used to characterize vanA-harboring plasmids as part of a routine molecular outbreak investigation and facilitates – based on plasmid sequence comparisons—the differentiation of outbreak-related isolates from sporadic cases.
Material and methods
Setting and study design
VREfm isolates were collected from screening swabs and clinical specimens at the University Hospital Münster (UHM) between 01/2022 and 02/2024. The UHM is a 1,450-bed tertiary-care hospital in Münster, Germany. In line with national recommendations, all high-risk patients (i. e., hemato-oncological patients) and patients with known VREfm colonization or infection are screened for VREfm [11]. In addition, Enterococci cultured from relevant clinical specimen such as biopsies, urine or primarily sterile body fluids undergo antimicrobial susceptibility testing. As part of a routine molecular surveillance strategy, isolates of patients that have tested positive for VREfm for the first time were sequenced by lrWGS. Only one isolate per patient was sequenced.
Microbiological methods
Rectal swabs were cultivated on VRE selective agar plates (VRESelect Agar, BioRad, Hercules, USA) and incubated at 5% CO2 and 36 C° ± 1 C° for at least 28 h. Clinical specimen were cultured on Columbia agar with 5% sheep blood (Becton Dickinson, Heidelberg, Germany) and incubated at 36 C° ± 1 C° up to 72 h. Bacterial species were identified using matrix-assisted laser desorption/ionization time-of-flight mass spectrometry (MALDI-TOF/MS) (MALDI Microflex® LT or MALDI Biotyper Sirius one IVD System, Bruker, Bremen, Germany) with identification scores above 2.0. Antimicrobial susceptibility testing was performed using the EUCAST disk diffusion test or a Vitek2 automated system (bioMérieux®, Marcy l′Étoile, France) applying the 2022 EUCAST clinical breakpoints. Environmental sampling was performed using polywipes (mwe, Corsham, Wiltshire, UK). Swabs were incubated in Tryptic Soy Broth containing lecithin tween (Merck Millipore, Eppelheim, Germany) for 24 h at 37 °C. Samples were plated on Columbia blood agar (Thermo Scientific, Schwerte, Germany) and VRE selective agar (VRESelect, Bio-Rad) and incubated for 28 h at 36 C° ± 1 °C. Vancomycin resistance was confirmed for all isolates by presence of the van genotype (eazyplex®VRE, amplex, Gars-Bahnhof, Germany).
Whole genome sequencing methodology
Genomic DNA of bacterial isolates were extracted using either Monarch® Genomic DNA Purification Kit (New England Biolabs, Ipswich, MA, USA) or ZymoBIOMICS 96 MagBead DNA Kit with Lysis tubes (Zymo Research, Freiburg, Germany) as described in the manufacturer's protocol and sequenced on a PacBio® Sequel IIe system (Pacific Biosciences, Menlo Park, CA, USA) using the SMRTbell® Express Template Prep Kit 2.0 (Pacific Biosciences Inc., Menlo Park, CA, USA). Sequencing Data was assembled de novo using the SMRT® Link software suite 11 with default parameters. For core genome multilocus sequence typing (cgMLST), the published cgMLST scheme for E. faecium was used [12]. The following quality control and exclusion criteria were applied: duplicates, other species and contaminated samples were excluded as well as sample with low data quality (presence of cgMLST targets < 95%), an average coverage < 15 and samples without van resistance genes.
Analyses of WGS data
After lrWGS and de novo assembly, the genomes were further analyzed by different tools implemented in Ridom SeqSphere+ software version 10 (Ridom GmbH, Münster, Germany). We characterized the genetic relationship of the isolates using multilocus sequence typing (MLST), sequence type (ST) and, clonal complex (CC) assignment for a broader grouping of genotypes. The cgMLST [12] and the complex type (CT) were assigned in accordance to the cgMLST database (www.cgMLST.org) for high discrimination of genotypes. MLST STs were identified using the scheme for E. faecium [13] implemented in Ridom SeqSphere+ (Ridom GmbH). Antimicrobial resistance (AMR) genes and their location were determined using target gene sets based on NCBI AMRFinderPlus [14]. Based on the allelic profiles from cgMLST [12]; we constructed a minimum-spanning tree to characterize the genetic relationships between isolates. Based on previously published results pairs of isolates with a cgMLST distance of ≤ 3 were followed up by the infection control team to identify potential transmission cases [15].
To analyze plasmids, contigs were further characterized to predict replicon type, relaxase type and mobility using MOB-suite software 3.1.8 [16] and all plasmids were compared and clustered using Mash (21 k-mers, sketch size 10,000, Mash distance ≤ 0.001) [17, 18]. Annotations were performed using Bakta 1.10.3 and the database v.5.1.0 [19].
Forty-two additional VREfm isolates were used to construct a database for a comprehensive comparison of vanA plasmids associated with the outbreak event as well as local plasmids.
Visualization
Minimum-spanning trees were created with Ridom SeqSphere+ (Ridom GmbH) based on cgMLST [12] allelic distances. The plasmid map of the annotated representative outbreak associated plasmid was created with SnapGeneViewer® 7.2 (SnapGene® software, Dotmatics; available at snapgene.com). The plasmid comparison was aligned with blast v2.16.0 [20] and visualized by pyGenomeViz v1.5.0 with pgv-gui [21] using 1,000 bp as the minimum comparison length.
Statistics
All statistical analysis was performed using basic R v. 4.4.0 [22] and package dplyr.
Epidemiological evaluation of the outbreak
Patient data were evaluated by infection control staff based on patients′ medical records and interviews with nursing or medical staff on site. In addition, the following criteria were used:
1. (1)
Contact within the department: the patient pair was admitted to the department, overlapping for at least one calendar day within the hospital admission.
2. (2)
Ward contact: the patient pair was admitted to the same ward, overlapping for at least one calendar day within the hospital admission.
3. (3)
Room contact: the patient pair was admitted to the same room, overlapping for at least one calendar day within the hospital admission.
Results
Characteristics of VRE isolates during study period
As a first step we wanted to capture the current epidemiology of VREfm at our hospital. During an observation period of 26 months, 446 VREfm isolates collected at the UHM were sequenced by lrWGS. Of these, 255 VREfm had a vanA genotype (57.17%) and 189 a vanB genotype (42.38%); two isolates harbored a combined vanA/B genotype. Isolates were detected in screening samples (n = 375, 84.08%) as well as in different clinical samples (15.92%). The median age of patients was 65 years (IQR 55–73) and most patients were male (n = 273, 61.21% vs. n = 173, 38.79%). MLST analysis revealed that 55% of the isolates belong to ST80 (n = 245) and 40% to ST117, respectively (Supp. Table 1). The majority of ST80 had a vanA genotype (85.10%) and ST117 were predominantly a vanB genotype (82.54%) (Supp. Table 1). The vanA/B isolates belong to ST117/CT71 and ST80/CT6045.
Detailed analysis of VREfm outbreak event
In the beginning of 2022, we noticed an increase of vanA positive VREfm isolates from neighboring wards. In total, 22 VREfm isolates were identified in screening samples between February 2022 and September 2022. Out of 22 colonized patients, nine were female and 13 male with a median age of 64 (IQR 53 -67). Nineteen cases were identified as nosocomial. As the situation fulfilled epidemiological outbreak criteria, we initiated an outbreak investigation [23]. All isolates were subjected to lrWGS to investigate if isolates were genetically closely related and a clonal transmission within the hospital admission seemed possible. The isolates were characterized as ST80/CT1470 and CC17, harboring a vanA positive plasmid. As part of infection control measures, we performed environmental sampling from the affected ward in March 2022. We sampled high-touch surfaces or areas exclusively frequented by healthcare workers (Supp. Table 2). Here, we could detect eight VREfm from environmental sampling that shared the same ST and vanA genotype indicating possible indirect transmissions through surfaces. cgMLST of all 30 isolates confirmed close genetic relationship (Fig. 1). Detailed epidemiological evaluation corroborated with the genotypic information and revealed connections for possible nosocomial transmission routes in most cases, as many patients shared a room during their hospital stay (Fig. 2).
[IMAGE OMITTED: SEE PDF]
[IMAGE OMITTED: SEE PDF]
Next, we analyzed the plasmids of these 30 isolates. In total, the isolates contained 165 plasmids. Regarding to vanA genes, four isolates contained two vanA positive plasmids, leading to a total number of 34 plasmids that harbor vanA. The majority of vanA gene clusters comprised all associated genes, i. e. vanA, vanHA, vanRA, vanSA, vanXA, vanYA, vanZA (Supp. Figure 1). Most vanA plasmids had a size of 23.9 kb, were predicted non-mobilizable and contained no other antibiotic resistance genes. The replicon type was identified as rep_cluster_889. In addition, the vanA plasmids of the outbreak-associated isolates showed Mash distances ≤ 0.001, indicating a high degree of similarity.
Comparison with other vanA positive isolates
After enhanced infection control measures, including intensified surface disinfection, were established on the affected ward, no further transmission of this particular VREfm clone was detected. Next, we wanted to investigate if there was any ongoing transmission of the vanA carrying plasmid associated with this outbreak event. Hence, we compared the outbreak-associated isolates with 42 additional VREfm isolates from the same department collected during the entire observation period. These isolates match the overall population of vanA VREfm isolates at our hospital (Supp. Table 1). Overall, the comparative isolates harbored 58 vanA plasmids and could be categorized into eight plasmid groups including the outbreak-associated plasmids (Fig. 3). Of these, 14 comparative isolates harbored two or three vanA plasmids.
[IMAGE OMITTED: SEE PDF]
cgMLST analysis revealed a minimal allelic distance of 8 alleles to the outbreak-associated isolates. Interestingly, plasmids associated with the outbreak event could be clearly distinguished from comparative ones (Table 1, Supp. Figure 2, Supp. Table 3). The maximum Mash distance within the outbreak-associated VREfm cluster was 0.001, while the most similar plasmids of the comparison isolates showed Mash distances between 0.0077 to 0.0103 (Supp. Table 4) compared to the outbreak-associated plasmid group. For example, a Mash distance of 0.0077 differentiated the plasmids of the outbreak-associated plasmid group to the plasmid of isolate A32543 from plasmid group 2. Therefore, we did not find any evidence of ongoing plasmid outbreak after the clonal transmission event.
[IMAGE OMITTED: SEE PDF]
Until the time of writing, the plasmid detected in the outbreak isolates has not been identified in any database. The most similar plasmid in the database PLSDB was NZ_AP026775.1 from Hanoi in Vietnam with a Mash distance of 0.0061 (sketch size for DB search is 1,000) which is 28.5 kb larger (Supp. Figure 3). Even a blast search at NCBI only detected plasmids that are over 4.0 kb larger than our outbreak-associated plasmid with only 23.9 kb (Supp. Figure 3). The first three hits at NCBI were CP059749.1, CP059767.1, MW821651.1.
Discussion
Here we present a retrospective analysis of the VREfm population in a German tertiary care hospital between 2022 and 2024 and report a detailed cluster investigation concerning a VREfm clone including the analysis of its vanA plasmid.
In our dataset of 446 VREfm isolates, the majority were vanA positive (57.17%). This result is in line with other national reports and neighboring European countries, where a switch to vanA positive VREfm has been observed after vanB positive isolates had dominated the population for many years [24,25,26]. Overall, the epidemiological data described in our study matches observations from other hospitals in Germany and Europe. Therefore, our data appears to be a good representation of the hospital-associated VREfm population. Our report is based on a single hospital, yet we believe the conclusions are applicable to other hospitals with a similar VREfm epidemiology.
The reported outbreak event affected 22 immunocompromised patients, a well-known risk group for VREfm colonization and infection [27, 28]. The VREfm isolates associated with the event were identified as ST80/CT1470 vanA positive, a clone frequently involved in hospital transmission and outbreaks [29]. As ST80 is a common nosocomial VREfm strain in German hospitals, MLST typing is not sufficient to investigate nosocomial transmission chains [24, 30]. For this reason, we used the highly discriminatory cgMLST-based approach based on the allelic profiles of up to 1,423 target genes to identify potential transmission events. Previously published studies used cgMLST distances of ≤ 3 for VRE transmission clusters [15]. We used this cgMLST threshold as a first guide to identify potential transmission cases and followed these cases up with detailed contact tracing.
As we analyzed the lrWGS data of the isolates, we noticed the isolates were not only closely genetically related based on cgMLST, but also the “primary” vanA plasmid showed little sequence variation across all outbreak-associated isolates even in environmental samples (Fig. 3). The environmental samples were collected from surfaces or areas only frequented by health care workers to show that the detection of these VREfm is evidence for insufficient hand hygiene or surface cleaning. Genetically closely related VREfm isolates in this context are consistent with a clonal outbreak of the isolates through direct contact, i. e., shared rooms as well as through indirect contact, i. e., contaminated surfaces.
Because of the high genetic similarity and low mutation rate [31], the discriminatory power of established genomic analysis methods for VREfm is considered low and outbreak events can potentially be overestimated [15]. This poses a challenge for molecular based infection control investigations. Our results suggest that an analysis of vanA plasmids can support outbreak analysis, as identical plasmids present additional evidence for a close genetic relationship between isolates and clonal transmission. On the other hand, analysis of vanA plasmids can be used to rule out isolates. For example, there are several occasions where isolates are closely related based on cgMLST with an allelic distance of 0 or 1, but their plasmids differ markedly (A28598 [no plasmid group assigned], A34533 [no plasmid group assigned], A29349 [plasmid group 2]). This observation corroborated with our findings that there were neither direct contact between patients nor evidence of indirect transmissions via surfaces in these cases.
Occasionally, we identified plasmid groups, i. e., 2 and 3 that were present in isolates with higher cgMLST allelic distances (> 5 alleles). These cases might represent genetically stable vanA plasmids that are well-adapted in the VREfm population. It remains unknown, whether vanA plasmids are exchanged within the host between different strains of bacteria. Unfortunately, these questions cannot be answered with our dataset. Here, studies investigating a higher number of isolates per patient might be helpful to determine the impact of plasmids for the dissemination of VREfm.
After the enhanced infection control measures had been established, no genetically related VREfm isolates were detected in the meantime. Using a Mash based approach [18]; we found no evidence for horizontal gene transfer (HGT) or persistence of the plasmid in the affected department. This observation is in line with our characterization that the plasmid did not encode a relaxase and was therefore classified as “non-mobilizable” by MOB-suite (Table 1). HGT is regarded a key mechanism how antimicrobial resistance genes are transferred in Gram-negative enterobacteria [32, 33]. Currently less studies have investigated the HGT of vanA plasmids. For VREfm, smaller mobile genetic elements might also play an important role for the transfer of resistance genes. In fact, several studies only show the analysis of transposons containing vanA genes [34, 35] or evidence of HGT of Tn1546-like structures instead of plasmids [36, 37]. On this note, one limitation of our study is that it solely relies on in silico analysis, therefore, the mobility classification is based on the current state of knowledge, but has not been experimentally proven as part of this study. As Ares-Arroyo et al. have shown previously the number of as “non-mobilizable” characterized plasmids might be overestimated [38].
Hospital surfaces, medical devices and persistence in the environment play an important role in the dissemination of VREfm in outbreaks [39, 40]. In fact, we also detected outbreak-associated isolates on relevant high-touch surfaces such as an electronic patient chart and computer in the nurses’ station. For Gram-negative multidrug resistant enterobacteria, hospital sink drains have been well-described as potential reservoir, where resistance plasmids are exchanged between different bacterial species causing prolonged outbreaks [41, 42]. So far, less is known about where vanA plasmids are exchanged in the hospital environment, i.e. sink drains or surfaces. This question warrants further investigation to improve targeted infection control measures against VREfm in the hospital setting.
Plasmids may play a role in the rapid rise of vanA positive isolates in the hospital setting. It seems plausible that the high stability of vanA plasmids and the maintenance of more than one vanA plasmids leads to a higher capability for adaptation to new and different environments. In fact, our data showed several isolates carrying more than one vanA plasmid (n = 18). However, larger datasets are necessary to address this question.
Conclusions
vanA plasmid analysis offers an additional dimension to WGS data for outbreak investigations. Furthermore, analysis of vanA plasmids in the hospital setting can improve our understanding how VREfm can persist and spread in hospitals.
Data availability
The assemblies of the 72 analyzed VREfm are available at NCBI in the BioProject: BioProject number PRJNA1177408.
Abbreviations
AMR:
Antimicrobial resistance
CC:
Clonal complex
CDC:
Centers for Disease Control and Prevention
cgMLST:
Core genome multilocus sequence typing
CT:
Complex type
EARS-Net:
European antimicrobial resistance surveillance network
E. faecium:
Enterococcus faecium
EUCAST:
European Committee on Antimicrobial Susceptibility Testing
HGT:
Horizontal gene transfer
IQR:
Interquartile range
lrWGS:
Long-read whole genome sequencing
MALDI-TOF/MS:
Matrix-assisted laser desorption/ionization time-of-flight mass spectrometry
Mash:
MinHash: method to compare DNA sequences
MLST:
Multilocus sequence typing
NCBI:
National Center for Biotechnology Information
ST:
Sequence type
UHM:
University Hospital Münster
van:
A/H/R/S/X/Y/Z vancomycin resistance genes or vanA gene locus
VREfm:
Vancomycin-resistant Enterococcus faecium
WGS:
Whole genome sequencing
National Center for Emerging and Zoonotic Infectious Diseases (U.S.), Division of Healthcare Quality Promotion. COVID-19: U.S. Impact on Antimicrobial Resistance, Special Report 2022. https://doi.org/10.15620/cdc:117915.
European Centre for Disease Prevention and Control. Antimicrobial resistance in the EU/EEA (EARS-Net) - Annual Epidemiological Report 2022 2023. Stockholm. https://www.ecdc.europa.eu/en/publications-data/surveillance-antimicrobial-resistance-europe-2022.
Cimen C, Berends MS, Bathoorn E, Lokate M, Voss A, Friedrich AW, et al. Vancomycin-resistant enterococci (VRE) in hospital settings across European borders: a scoping review comparing the epidemiology in the Netherlands and Germany. Antimicrob Resist Infect Control. 2023;12:78. https://doi.org/10.1186/s13756-023-01278-0.
Bender JK, Hermes J, Zabel LT, Haller S, Mürter N, Blank H-P, et al. Controlling an Unprecedented Outbreak with Vancomycin-Resistant Enterococcus faecium in Germany, October 2015 to November 2019. Microorganisms 2022. https://doi.org/10.3390/microorganisms10081603.
Harris SR, Cartwright EJP, Török ME, Holden MTG, Brown NM, Ogilvy-Stuart AL, et al. Whole-genome sequencing for analysis of an outbreak of meticillin-resistant Staphylococcus aureus: a descriptive study. Lancet Infect Dis. 2013;13:130–6. https://doi.org/10.1016/S1473-3099(12)70268-2.
Islam M, Sharon B, Abaragu A, Sistu H, Akins RL, Palmer K. Vancomycin Resistance in Enterococcus faecium from the Dallas, Texas, Area Is Conferred Predominantly on pRUM-Like Plasmids. mSphere. 2023;8:e0002423. https://doi.org/10.1128/msphere.00024-23.
Arredondo-Alonso S, Top J, Corander J, Willems RJL, Schürch AC. Mode and dynamics of vanA-type vancomycin resistance dissemination in Dutch hospitals. Genome Med. 2021;13:1. https://doi.org/10.1186/s13073-020-00825-3.
Arredondo-Alonso S, Willems RJ, van Schaik W, Schürch AC. On the (im)possibility of reconstructing plasmids from whole-genome short-read sequencing data. Microb Genom. 2017;3:e000128. https://doi.org/10.1099/mgen.0.000128.
Arredondo-Alonso S, Top J, McNally A, Puranen S, Pesonen M, Pensar J, et al. Plasmids Shaped the Recent Emergence of the Major Nosocomial Pathogen Enterococcus faecium. mBio 2020. https://doi.org/10.1128/mBio.03284-19.
Pecora N, Zhao X, Nudel K, Hoffmann M, Li N, Onderdonk AB, et al. Diverse Vectors and Mechanisms Spread New Delhi Metallo-β-Lactamases among Carbapenem-Resistant Enterobacteriaceae in the Greater Boston Area. Antimicrob Agents Chemother. 2019. https://doi.org/10.1128/AAC.02040-18.
Hygienemaßnahmen zur Prävention der Infektion durch Enterokokken mit speziellen Antibiotikaresistenzen : Empfehlung der Kommission für Krankenhaushygiene und Infektionsprävention (KRINKO) beim Robert Koch-Institut. Bundesgesundheitsblatt Gesundheitsforschung Gesundheitsschutz. 2018;61:1310–61. https://doi.org/10.1007/s00103-018-2811-2.
de Been M, Pinholt M, Top J, Bletz S, Mellmann A, van Schaik W, et al. Core Genome Multilocus Sequence Typing Scheme for High- Resolution Typing of Enterococcus faecium. J Clin Microbiol. 2015;53:3788–97. https://doi.org/10.1128/JCM.01946-15.
Homan WL, Tribe D, Poznanski S, Li M, Hogg G, Spalburg E, et al. Multilocus sequence typing scheme for Enterococcus faecium. J Clin Microbiol. 2002;40:1963–71. https://doi.org/10.1128/JCM.40.6.1963-1971.2002.
Feldgarden M, Brover V, Haft DH, Prasad AB, Slotta DJ, Tolstoy I, et al. Validating the AMRFinder Tool and Resistance Gene Database by Using Antimicrobial Resistance Genotype-Phenotype Correlations in a Collection of Isolates. Antimicrob Agents Chemother. 2019. https://doi.org/10.1128/AAC.00483-19.
Rath A, Kieninger B, Mirzaliyeva N, Schmid S, Mester P, Schneider-Brachert W. The genome-oriented surveillance of vancomycin-resistant enterococci shows a clear misclassification of nosocomial transmission events. Clin Microbiol Infect. 2024;30:1086–8. https://doi.org/10.1016/j.cmi.2024.04.010.
Robertson J, Nash JHE. MOB-suite: software tools for clustering, reconstruction and typing of plasmids from draft assemblies. Microb Genom. 2018. https://doi.org/10.1099/mgen.0.000206.
Scherff N, Rothgänger J, Weniger T, Mellmann A, Harmsen D. Real-time plasmid transmission detection pipeline. Microbiol Spectr. 2024;12:e0210024. https://doi.org/10.1128/spectrum.02100-24.
Ondov BD, Treangen TJ, Melsted P, Mallonee AB, Bergman NH, Koren S, Phillippy AM. Mash: fast genome and metagenome distance estimation using MinHash. Genome Biol. 2016;17:132. https://doi.org/10.1186/s13059-016-0997-x.
Schwengers O, Jelonek L, Dieckmann MA, Beyvers S, Blom J, Goesmann A. Bakta: rapid and standardized annotation of bacterial genomes via alignment-free sequence identification. Microb Genom. 2021. https://doi.org/10.1099/mgen.0.000685.
Camacho C, Coulouris G, Avagyan V, Ma N, Papadopoulos J, Bealer K, Madden TL. BLAST+: architecture and applications. BMC Bioinformatics. 2009;10:421. https://doi.org/10.1186/1471-2105-10-421.
Shimoyama Y. pyGenomeViz: A Genome Visualization Python Package for Comparative Genomics. https://github.com/moshi4/pyGenomeViz. Accessed 4 Sep 2024.
R Core Team. R: A language and environment for statistical computing 2023.
World Health Organization. Disease outbreaks. https://www.emro.who.int/health-topics/disease-outbreaks/index.html. Accessed 4 Sep 2024.
Robert-Koch-Institut. Eigenschaften, Häufigkeit und Verbreitung von Vancomycin-resistenten Enterokokken in Deutschland – Update 2021/2022. 2023. https://www.rki.de/DE/Content/Infekt/EpidBull/Archiv/2023/28/Art_01.html.
Jochim-Vukosavic A, Schwab F, Knegendorf L, Schlüter D, Bange F-C, Ebadi E, Baier C. Epidemiology and infection control of vancomycin-resistant enterococci at a German university hospital: A three-year retrospective cohort study. PLoS ONE. 2024;19:e0297866. https://doi.org/10.1371/journal.pone.0297866.
Werner G, Neumann B, Weber RE, Kresken M, Wendt C, Bender JK. Thirty years of VRE in Germany - “expect the unexpected”: The view from the National Reference Centre for Staphylococci and Enterococci. Drug Resist Updat. 2020;53:100732. https://doi.org/10.1016/j.drup.2020.100732.
DiazGranados CA, Jernigan JA. Impact of vancomycin resistance on mortality among patients with neutropenia and enterococcal bloodstream infection. J Infect Dis. 2005;191:588–95. https://doi.org/10.1086/427512.
Eichel VM, Last K, Brühwasser C, von Baum H, Dettenkofer M, Götting T, et al. Epidemiology and outcomes of vancomycin-resistant enterococcus infections: a systematic review and meta-analysis. J Hosp Infect. 2023;141:119–28. https://doi.org/10.1016/j.jhin.2023.09.008.
Dyrkell F, Giske CG, Fang H. Epidemiological typing of ST80 vancomycin-resistant Enterococcus faecium: core genome multilocus sequence typing versus single nucleotide polymorphism-based typing. J Glob Antimicrob Resist. 2021;25:119–23. https://doi.org/10.1016/j.jgar.2021.03.005.
Correa-Martínez CL, Jurke A, Schmitz J, Schaumburg F, Kampmeier S, Mellmann A. Molecular Epidemiology of Vancomycin-Resistant Enterococci Bloodstream Infections in Germany: A Population-Based Prospective Longitudinal Study. Microorganisms. 2022. https://doi.org/10.3390/microorganisms10010130.
Guzman Prieto AM, van Schaik W, Rogers MRC, Coque TM, Baquero F, Corander J, Willems RJL. Global Emergence and Dissemination of Enterococci as Nosocomial Pathogens: Attack of the Clones? Front Microbiol. 2016;7:788. https://doi.org/10.3389/fmicb.2016.00788.
Castañeda-Barba S, Top EM, Stalder T. Plasmids, a molecular cornerstone of antimicrobial resistance in the One Health era. Nat Rev Microbiol. 2024;22:18–32. https://doi.org/10.1038/s41579-023-00926-x.
Marimuthu K, Venkatachalam I, Koh V, Harbarth S, Perencevich E, Cherng BPZ, et al. Whole genome sequencing reveals hidden transmission of carbapenemase-producing Enterobacterales. Nat Commun. 2022;13:3052. https://doi.org/10.1038/s41467-022-30637-5.
Liu S, Li Y, He Z, Wang Y, Wang J, Jin D. A molecular study regarding the spread of vanA vancomycin-resistant Enterococcus faecium in a tertiary hospital in China. J Glob Antimicrob Resist. 2022;31:270–8. https://doi.org/10.1016/j.jgar.2022.10.010.
Wongnak K, Pattanachaiwit S, Rattanasirirat W, Limsrivanichakorn S, Kiratisin P, Assanasen S, Leelaporn A. First characterization of Tn1546-like structures of vancomycin-resistant Enterococcus faecium Thai isolates. J Infect Chemother. 2021;27:991–8. https://doi.org/10.1016/j.jiac.2021.02.013.
Huang Y-C, Chen F-J, Huang I-W, Wu H-C, Kuo S-C, Huang T-W, Lauderdale T-L. Clonal expansion of Tn1546-like transposon-carrying vancomycin-resistant Enterococcus faecium, a nationwide study in Taiwan, 2004–2018. J Glob Antimicrob Resist. 2024;39:100–8. https://doi.org/10.1016/j.jgar.2024.06.005.
Hsieh Y-C, Lee W-S, Ou T-Y, Hsueh P-R. Clonal spread of CC17 vancomycin-resistant Enterococcus faecium with multilocus sequence type 78 (ST78) and a novel ST444 in Taiwan. Eur J Clin Microbiol Infect Dis. 2010;29:25–30. https://doi.org/10.1007/s10096-009-0810-9.
Ares-Arroyo M, Coluzzi C, Rocha EPC. Origins of transfer establish networks of functional dependencies for plasmid transfer by conjugation. Nucleic Acids Res. 2023;51:3001–16. https://doi.org/10.1093/nar/gkac1079.
Correa-Martinez CL, Tönnies H, Froböse NJ, Mellmann A, Kampmeier S. Transmission of Vancomycin-Resistant Enterococci in the Hospital Setting: Uncovering the Patient-Environment Interplay. Microorganisms. 2020. https://doi.org/10.3390/microorganisms8020203.
Park S, Bae S, Kim EO, Chang E, Kim MJ, Chong YP, et al. The impact of discontinuing single-room isolation of patients with vancomycin-resistant enterococci: a quasi-experimental single-centre study in South Korea. J Hosp Infect. 2024;147:77–82. https://doi.org/10.1016/j.jhin.2024.02.025.
Diorio-Toth L, Wallace MA, Farnsworth CW, Wang B, Gul D, Kwon JH, et al. Intensive care unit sinks are persistently colonized with multidrug resistant bacteria and mobilizable, resistance-conferring plasmids. mSystems. 2023;8:e0020623. https://doi.org/10.1128/msystems.00206-23.
Tsukada M, Miyazaki T, Aoki K, Yoshizawa S, Kondo Y, Sawa T, et al. The outbreak of multispecies carbapenemase-producing Enterobacterales associated with pediatric ward sinks: IncM1 plasmids act as vehicles for cross-species transmission. Am J Infect Control. 2024;52:801–6. https://doi.org/10.1016/j.ajic.2024.02.013.
© 2025. This work is licensed under http://creativecommons.org/licenses/by/4.0/ (the “License”). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License.